ann out, page-31

We've been waiting a long time for a positive Paloma update. It's promised so much but as yet has not delivered. What's happening with production testing? Is this why the CR was oversubscribed? Are we now going to get a wonderful update only to be shat on from a great height by the 100m new shares for the boys?

If this occurs you would have to question why the CR was done before - not after the update. Whose interest are management looking after? The shareholders or institutions?

All valid questions in my books.